✦ LIBER ✦

A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil. A preliminary report

✍ Scribed by Fred Ansfield; Jerome Klotz; Thomas Nealon; Guillermo Ramirez; John Minton; George Hill; William Wilson; Hugh Davis Jr.; George Cornell

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 464 KB
Volume: 39
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197701)39:1<34::aid-cncr2820390107>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative study between daily and 5-da

Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen

✍ Masato Makino; Hidehiko Shoji; Daiki Takemoto; Takuya Honboh; Seiichi Nakamura; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 131 KB

A phase III randomized study of 5-fluoro

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

✍ Noe Kyeong Kim; Young Suk Park; Dae Seog Heo; Cheolwon Suh; Si Young Kim; Keun C 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

A phase III trial on the therapy of adva

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

✍ Stephen Cullinan; Charles G. Moertel; Harry S. Wieand; Allan J. Schutt; James E. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 2 views

A phase III trial of 5-fluorouracil and

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study

✍ Michael J. O'Connell 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

The continuous arterial infusion of 5-fl

The continuous arterial infusion of 5-fluorouracil as a therapeutic adjunct in the treatment of advanced carcinoma of the bladder and prostate. A preliminary report

✍ James E. Nevin III; Irving Melnick; John T. Baggerly Jr.; Allen Hoffman; Ralph R 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 779 KB

Neo-adjuvant chemo-(immuno-)therapy of a

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

✍ Giovanni Mantovani; Vittorio Gebbia; Mario Airoldi; Cesare Bumma; Paolo Contu; A 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 182 KB